Osteoarthritis Pain Medicine Market Report

Global Osteoarthritis Pain Medicine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 27, 2022
  • PAGES：229
  • REPORT CODE：GMM816722
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Osteoarthritis Pain Medicine market report explains the definition, types, applications, major countries, and major players of the Osteoarthritis Pain Medicine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Johnson & Johnson

    • Eli Lilly

    • Iroko Pharmaceuticals

    • Mylan

    • Bayer

    • GlaxoSmithKline

    • Daiichi Sankyo

    • Astellas Pharma

    • Pfizer

    • Tide Pharmaceutical

    • Abbott

    • Abiogen Pharma

    • Sanofi

    • Horizon Pharma

    • Hengrui Pharmaceutical

    • Novartis

    • Almatica Pharma

    • TEVA

    By Type:

    • Oral

    • Injection

    • External

    By End-User:

    • Medical Care

    • Personal Care

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Osteoarthritis Pain Medicine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Osteoarthritis Pain Medicine Outlook to 2028- Original Forecasts

    • 2.2 Osteoarthritis Pain Medicine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Osteoarthritis Pain Medicine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Osteoarthritis Pain Medicine Market- Recent Developments

    • 6.1 Osteoarthritis Pain Medicine Market News and Developments

    • 6.2 Osteoarthritis Pain Medicine Market Deals Landscape

    7 Osteoarthritis Pain Medicine Raw Materials and Cost Structure Analysis

    • 7.1 Osteoarthritis Pain Medicine Key Raw Materials

    • 7.2 Osteoarthritis Pain Medicine Price Trend of Key Raw Materials

    • 7.3 Osteoarthritis Pain Medicine Key Suppliers of Raw Materials

    • 7.4 Osteoarthritis Pain Medicine Market Concentration Rate of Raw Materials

    • 7.5 Osteoarthritis Pain Medicine Cost Structure Analysis

      • 7.5.1 Osteoarthritis Pain Medicine Raw Materials Analysis

      • 7.5.2 Osteoarthritis Pain Medicine Labor Cost Analysis

      • 7.5.3 Osteoarthritis Pain Medicine Manufacturing Expenses Analysis

    8 Global Osteoarthritis Pain Medicine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Osteoarthritis Pain Medicine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Osteoarthritis Pain Medicine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Osteoarthritis Pain Medicine Market Outlook by Types and Applications to 2022

    • 9.1 Global Osteoarthritis Pain Medicine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Injection Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global External Consumption and Growth Rate (2017-2022)

    • 9.2 Global Osteoarthritis Pain Medicine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Medical Care Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Personal Care Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Osteoarthritis Pain Medicine Market Analysis and Outlook till 2022

    • 10.1 Global Osteoarthritis Pain Medicine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.2.2 Canada Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.2.3 Mexico Osteoarthritis Pain Medicine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.3.2 UK Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.3.3 Spain Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.3.4 Belgium Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.3.5 France Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.3.6 Italy Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.3.7 Denmark Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.3.8 Finland Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.3.9 Norway Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.3.10 Sweden Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.3.11 Poland Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.3.12 Russia Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.3.13 Turkey Osteoarthritis Pain Medicine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.4.2 Japan Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.4.3 India Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.4.4 South Korea Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.4.5 Pakistan Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.4.6 Bangladesh Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.4.7 Indonesia Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.4.8 Thailand Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.4.9 Singapore Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.4.10 Malaysia Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.4.11 Philippines Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.4.12 Vietnam Osteoarthritis Pain Medicine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.5.2 Colombia Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.5.3 Chile Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.5.4 Argentina Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.5.5 Venezuela Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.5.6 Peru Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.5.8 Ecuador Osteoarthritis Pain Medicine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.6.2 Kuwait Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.6.3 Oman Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.6.4 Qatar Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Osteoarthritis Pain Medicine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.7.2 South Africa Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.7.3 Egypt Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.7.4 Algeria Osteoarthritis Pain Medicine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Osteoarthritis Pain Medicine Consumption (2017-2022)

      • 10.8.2 New Zealand Osteoarthritis Pain Medicine Consumption (2017-2022)

    11 Global Osteoarthritis Pain Medicine Competitive Analysis

    • 11.1 Johnson & Johnson

      • 11.1.1 Johnson & Johnson Company Details

      • 11.1.2 Johnson & Johnson Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Johnson & Johnson Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.1.4 Johnson & Johnson Osteoarthritis Pain Medicine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Eli Lilly

      • 11.2.1 Eli Lilly Company Details

      • 11.2.2 Eli Lilly Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Eli Lilly Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.2.4 Eli Lilly Osteoarthritis Pain Medicine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Iroko Pharmaceuticals

      • 11.3.1 Iroko Pharmaceuticals Company Details

      • 11.3.2 Iroko Pharmaceuticals Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Iroko Pharmaceuticals Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.3.4 Iroko Pharmaceuticals Osteoarthritis Pain Medicine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Mylan

      • 11.4.1 Mylan Company Details

      • 11.4.2 Mylan Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Mylan Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.4.4 Mylan Osteoarthritis Pain Medicine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Bayer

      • 11.5.1 Bayer Company Details

      • 11.5.2 Bayer Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Bayer Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.5.4 Bayer Osteoarthritis Pain Medicine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 GlaxoSmithKline

      • 11.6.1 GlaxoSmithKline Company Details

      • 11.6.2 GlaxoSmithKline Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 GlaxoSmithKline Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.6.4 GlaxoSmithKline Osteoarthritis Pain Medicine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Daiichi Sankyo

      • 11.7.1 Daiichi Sankyo Company Details

      • 11.7.2 Daiichi Sankyo Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Daiichi Sankyo Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.7.4 Daiichi Sankyo Osteoarthritis Pain Medicine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Astellas Pharma

      • 11.8.1 Astellas Pharma Company Details

      • 11.8.2 Astellas Pharma Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Astellas Pharma Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.8.4 Astellas Pharma Osteoarthritis Pain Medicine Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Pfizer

      • 11.9.1 Pfizer Company Details

      • 11.9.2 Pfizer Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Pfizer Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.9.4 Pfizer Osteoarthritis Pain Medicine Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Tide Pharmaceutical

      • 11.10.1 Tide Pharmaceutical Company Details

      • 11.10.2 Tide Pharmaceutical Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Tide Pharmaceutical Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.10.4 Tide Pharmaceutical Osteoarthritis Pain Medicine Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Abbott

      • 11.11.1 Abbott Company Details

      • 11.11.2 Abbott Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Abbott Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.11.4 Abbott Osteoarthritis Pain Medicine Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Abiogen Pharma

      • 11.12.1 Abiogen Pharma Company Details

      • 11.12.2 Abiogen Pharma Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Abiogen Pharma Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.12.4 Abiogen Pharma Osteoarthritis Pain Medicine Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Sanofi

      • 11.13.1 Sanofi Company Details

      • 11.13.2 Sanofi Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Sanofi Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.13.4 Sanofi Osteoarthritis Pain Medicine Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Horizon Pharma

      • 11.14.1 Horizon Pharma Company Details

      • 11.14.2 Horizon Pharma Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Horizon Pharma Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.14.4 Horizon Pharma Osteoarthritis Pain Medicine Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Hengrui Pharmaceutical

      • 11.15.1 Hengrui Pharmaceutical Company Details

      • 11.15.2 Hengrui Pharmaceutical Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Hengrui Pharmaceutical Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.15.4 Hengrui Pharmaceutical Osteoarthritis Pain Medicine Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Novartis

      • 11.16.1 Novartis Company Details

      • 11.16.2 Novartis Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Novartis Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.16.4 Novartis Osteoarthritis Pain Medicine Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 Almatica Pharma

      • 11.17.1 Almatica Pharma Company Details

      • 11.17.2 Almatica Pharma Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 Almatica Pharma Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.17.4 Almatica Pharma Osteoarthritis Pain Medicine Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 TEVA

      • 11.18.1 TEVA Company Details

      • 11.18.2 TEVA Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 TEVA Osteoarthritis Pain Medicine Main Business and Markets Served

      • 11.18.4 TEVA Osteoarthritis Pain Medicine Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    12 Global Osteoarthritis Pain Medicine Market Outlook by Types and Applications to 2028

    • 12.1 Global Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global External Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Medical Care Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Personal Care Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Osteoarthritis Pain Medicine Market Analysis and Outlook to 2028

    • 13.1 Global Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.3.2 UK Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.3.5 France Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.4.3 India Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Osteoarthritis Pain Medicine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Osteoarthritis Pain Medicine

    • Figure of Osteoarthritis Pain Medicine Picture

    • Table Global Osteoarthritis Pain Medicine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Osteoarthritis Pain Medicine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Injection Consumption and Growth Rate (2017-2022)

    • Figure Global External Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Care Consumption and Growth Rate (2017-2022)

    • Figure Global Personal Care Consumption and Growth Rate (2017-2022)

    • Figure Global Osteoarthritis Pain Medicine Consumption by Country (2017-2022)

    • Table North America Osteoarthritis Pain Medicine Consumption by Country (2017-2022)

    • Figure United States Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Canada Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Table Europe Osteoarthritis Pain Medicine Consumption by Country (2017-2022)

    • Figure Germany Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure UK Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Spain Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure France Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Italy Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Finland Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Norway Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Poland Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Russia Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Table APAC Osteoarthritis Pain Medicine Consumption by Country (2017-2022)

    • Figure China Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Japan Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure India Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Table South America Osteoarthritis Pain Medicine Consumption by Country (2017-2022)

    • Figure Brazil Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Chile Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Peru Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Table GCC Osteoarthritis Pain Medicine Consumption by Country (2017-2022)

    • Figure Bahrain Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Oman Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Table Africa Osteoarthritis Pain Medicine Consumption by Country (2017-2022)

    • Figure Nigeria Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Table Oceania Osteoarthritis Pain Medicine Consumption by Country (2017-2022)

    • Figure Australia Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Osteoarthritis Pain Medicine Consumption and Growth Rate (2017-2022)

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Johnson & Johnson Osteoarthritis Pain Medicine Product Portfolio

    • Table Eli Lilly Company Details

    • Table Eli Lilly Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Eli Lilly Osteoarthritis Pain Medicine Product Portfolio

    • Table Iroko Pharmaceuticals Company Details

    • Table Iroko Pharmaceuticals Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Iroko Pharmaceuticals Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Iroko Pharmaceuticals Osteoarthritis Pain Medicine Product Portfolio

    • Table Mylan Company Details

    • Table Mylan Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Mylan Osteoarthritis Pain Medicine Product Portfolio

    • Table Bayer Company Details

    • Table Bayer Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Bayer Osteoarthritis Pain Medicine Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table GlaxoSmithKline Osteoarthritis Pain Medicine Product Portfolio

    • Table Daiichi Sankyo Company Details

    • Table Daiichi Sankyo Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Daiichi Sankyo Osteoarthritis Pain Medicine Product Portfolio

    • Table Astellas Pharma Company Details

    • Table Astellas Pharma Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Astellas Pharma Osteoarthritis Pain Medicine Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Pfizer Osteoarthritis Pain Medicine Product Portfolio

    • Table Tide Pharmaceutical Company Details

    • Table Tide Pharmaceutical Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tide Pharmaceutical Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Tide Pharmaceutical Osteoarthritis Pain Medicine Product Portfolio

    • Table Abbott Company Details

    • Table Abbott Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Abbott Osteoarthritis Pain Medicine Product Portfolio

    • Table Abiogen Pharma Company Details

    • Table Abiogen Pharma Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abiogen Pharma Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Abiogen Pharma Osteoarthritis Pain Medicine Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Sanofi Osteoarthritis Pain Medicine Product Portfolio

    • Table Horizon Pharma Company Details

    • Table Horizon Pharma Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Horizon Pharma Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Horizon Pharma Osteoarthritis Pain Medicine Product Portfolio

    • Table Hengrui Pharmaceutical Company Details

    • Table Hengrui Pharmaceutical Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hengrui Pharmaceutical Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Hengrui Pharmaceutical Osteoarthritis Pain Medicine Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Novartis Osteoarthritis Pain Medicine Product Portfolio

    • Table Almatica Pharma Company Details

    • Table Almatica Pharma Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Almatica Pharma Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table Almatica Pharma Osteoarthritis Pain Medicine Product Portfolio

    • Table TEVA Company Details

    • Table TEVA Osteoarthritis Pain Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table TEVA Osteoarthritis Pain Medicine Main Business and Markets Served

    • Table TEVA Osteoarthritis Pain Medicine Product Portfolio

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global External Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Care Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Personal Care Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Osteoarthritis Pain Medicine Consumption Forecast by Country (2022-2028)

    • Table North America Osteoarthritis Pain Medicine Consumption Forecast by Country (2022-2028)

    • Figure United States Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Osteoarthritis Pain Medicine Consumption Forecast by Country (2022-2028)

    • Figure Germany Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Osteoarthritis Pain Medicine Consumption Forecast by Country (2022-2028)

    • Figure China Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Osteoarthritis Pain Medicine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Osteoarthritis Pain Medicine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Osteoarthritis Pain Medicine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Osteoarthritis Pain Medicine Consumption Forecast by Country (2022-2028)

    • Figure Australia Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Osteoarthritis Pain Medicine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US